Gimv, a leading private equity investor, has acquired a majority stake in SpiraTec AG, a German provider of industrial automation, IT, and engineering services focused on the pharmaceutical, chemical, and broader process industries. The transaction, announced on November 19, 2026, is expected to close by the end of the year, pending regulatory approvals.

SpiraTec, founded in 2007 and headquartered in Speyer, Germany, delivers integrated end-to-end solutions combining automation, IT, and plant engineering. Its services span consulting, planning, commissioning, validation, maintenance, and optimization of production facilities. The company primarily serves pharmaceutical and chemical manufacturers, focusing on modernizing and optimizing existing plants.

With approximately EUR 90 million in annual revenue and over 650 employees operating from more than 40 locations across Germany, France, Italy, Austria, Switzerland, and the United States, SpiraTec has demonstrated strong organic growth alongside five acquisitions in recent years. The company’s founders and Co-CEOs, Andreas Schadt and Frank Heines, remain significantly invested and will continue leading the business.

Gimv’s investment aligns with its Smart Industries platform, which targets companies combining industrial expertise with digital intelligence. Ronald Bartel, Partner at Gimv Smart Industries, highlights SpiraTec’s robust track record and its strategic position to support advanced manufacturers in adopting AI-enabled and connected production technologies. He states, “SpiraTec’s combined expertise in automation, IT, and engineering provides a strong foundation for further growth and positions it well to help Europe’s advanced manufacturers adopt new technologies and strengthen their long-term competitiveness.”

The partnership aims to accelerate SpiraTec’s international growth both organically and through acquisitions, continuing its buy-and-build strategy. This approach is expected to consolidate fragmented automation service providers and expand SpiraTec’s footprint in key markets, including the US and several European countries.

Industry trends show increasing demand for secure, connected, and AI-enabled production processes, particularly in pharmaceutical and chemical manufacturing. SpiraTec’s integrated solutions and focus on digital transformation position it to capitalize on these trends, offering clients enhanced production optimization and long-term competitiveness.

Financial terms of the deal were not disclosed. The transaction is subject to customary closing conditions, including competition authority approvals. Gimv’s investment reflects its strategy to make larger individual investments in companies with strong international growth ambitions.

Looking ahead, SpiraTec plans to leverage Gimv’s capital and strategic guidance to expand its service offerings, integrate acquired companies, and enhance operational efficiencies. The company also faces integration challenges such as aligning diverse cultures and IT platforms across its geographically dispersed operations.

Founders Schadt and Heines express confidence in the partnership, noting, “With Gimv, we have found a partner who shares our long-term vision and has extensive experience in supporting companies with their international expansion and buy-and-build strategies. Together, we will continue to grow SpiraTec as a reliable partner for our customers and an attractive employer for our people.”

This acquisition strengthens SpiraTec’s position as a leading automation and digital transformation provider in the pharmaceutical and chemical process industries, enhancing its ability to serve advanced manufacturing clients across Europe and the US.

Share

"DealNews.ai is produced by the DealNews.ai editorial desk, which covers mergers and acquisitions, private equity and venture capital activity across Europe and the Benelux. Articles are based on company...